Test Price
2,800 AED✅ Home Collection Available
ICK Gene Endocrine-Cerebroosteodysplasia Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين ICK للاضطراب الغُدّي الدماغي العظمي (Endocrine-Cerebroosteodysplasia) بتقنية التسلسل الجيني المتقدم (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
ملخص تنفيذي: دقة تشخيصية بنسبة 99.9% عبر مختبر معتمد ISO 9001:2015، مع خدمة سحب الدم المنزلي المبرد بتوافق مع المعايير، وتوجيه سريري بعد الفحص، وتحقق مباشر من التأمين عبر الواتساب.
📋 Overview
The ICK Gene Endocrine-Cerebroosteodysplasia Genetic Test is a definitive next-generation sequencing analysis targeting all coding regions of the ICK gene. This test resolves the molecular etiology of this ultra-rare multi-system disorder characterized by endocrine, neurological, and skeletal dysplasia, enabling personalized therapeutic strategies.
A pre-test genetic counselling session with a certified clinical geneticist is mandatory to draw a detailed family pedigree and obtain informed consent, as required by UAE medical practice standards.
| Feature | Our Test (NGS) | Closest Alternative |
|---|---|---|
| Methodology | Next-Generation Sequencing (100% coding region coverage) | Sanger Sequencing (selected exons only) |
| Precision / Sensitivity | >99.9% for single nucleotide variants and indels | ~95% for targeted mutations |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Regulatory Compliance | DHA/MOHAP Licensed, ISO 9001:2015, UAE PDPL | Often limited to international reference labs |
🩺 Physician Insight & Safety Protocol
Clinical Insight from Dr. PRABHAKAR REDDY (DHA License: 61713011): "Navigating a rare diagnosis like Endocrine-Cerebroosteodysplasia is emotionally challenging for families. This NGS test provides molecular clarity, but it is essential to interpret results within the full clinical and pedigree context. A negative result does not exclude the diagnosis, and variant classification may evolve with updated databases."
⚕️ MEDICATION WARNING: Do not discontinue any prescribed medication (e.g., hormone replacement, anti-epileptics) without consulting your treating physician. Genetic test results require clinical correlation.
⛔ Safety Exclusion Criteria & ER Red Flags
Exclusion Criteria
- Recent whole blood transfusion (within 2 weeks).
- Inability to provide informed consent or confirm legal guardianship.
- Grossly hemolyzed or contaminated sample (recollection will be advised).
Emergency Red Flags (Seek Immediate Medical Care if Present)
- Acute adrenal insufficiency (hypotension, shock, hypoglycemia).
- Unexplained seizures or loss of consciousness.
- Pathological fractures without trauma.
- Severe metabolic acidosis or electrolyte imbalance.
This genetic test is a diagnostic aid, not an emergency tool. For acute symptoms, proceed to your nearest ER.
❓ Patient FAQ & Clinical Guidance
Q1: What exactly does the ICK gene test detect?
💬 In Brief: It detects pathogenic variants in the ICK gene linked to Endocrine-Cerebroosteodysplasia, covering endocrine anomalies, brain malformations, and skeletal dysplasia.
This NGS test screens all coding exons and exon–intron boundaries of the ICK gene for single nucleotide changes, small insertions/deletions, and copy number variations. A positive finding confirms the molecular diagnosis and informs tailored management, including endocrine replacement, anti-epileptic therapy, and orthopaedic surveillance.
بالعربية: يكتشف الفحص الطفرات الممرضة في جين ICK المسببة لمتلازمة الغدد الصماء-الدماغ-العظام، والتي تشمل تشوهات الغدد الصماء والدماغ والهيكل العظمي.
Q2: How is the sample collected for this genetic?
💬 In Brief: A small amount of whole blood, extracted DNA, or a drop of blood on an FTA card is sufficient; home phlebotomy is available across all emirates.
Our ISO-certified VIP mobile phlebotomy team visits your home, office, or hotel from 8 AM to 11 PM daily. The sample is transported in validated cold-chain containers to guarantee DNA integrity. For infants, a blood spot card is the least invasive option and is fully validated for NGS.
بالعربية: يمكن جمع العينة عبر سحب دم بسيط من الوريد أو وضع قطرة دم على بطاقة FTA، وتتوفر خدمة السحب المنزلي في جميع الإمارات على مدار اليوم.
Q3: What is the turnaround time and how will I receive the results?
💬 In Brief: Typically, results are delivered within 3 to 4 weeks via a secure encrypted PDF report, accompanied by a telephonic consultation with our clinical geneticist.
Once sequencing is complete, the data is analyzed by a board-certified molecular geneticist and reviewed by Dr. Reddy. You will receive a DHA-compliant report including variant classification (ACMG guidelines), clinical annotations, and actionable recommendations. A follow-up genetic counselling session can be arranged at no extra cost.
بالعربية: تستغرق النتائج عادة من 3 إلى 4 أسابيع، وتُرسل عبر تقرير PDF مشفر مع جلسة استشارة هاتفية لشرح النتائج مع أخصائي الوراثة السريرية المعتمد.
Lab Facility License No: 9834453 | ISO 9001:2015 Certified (INT/EGQ/2509DA/3139) | Licensed by DHA/MOHAP | Data Protection under Federal Decree-Law No. 41 of 2024, CDS Law 2026 & UAE PDPL.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians